Cite
HARVARD Citation
Jiang, H. et al. (n.d.). Anti‐CD19 chimeric antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia: An open‐label pragmatic clinical trial. American journal of hematology. 94 (10), pp. 1113-1122. [Online].